THROMBINNOV accelerates the development of innovative therapies by evaluating and de-risking their hemorrhagic and thrombotic risks as early as the preclinical phase.
| Website | http://www.thrombinnov.com |
| Employees | 3 (2 on RocketReach) |
| Industry | Biotechnology Research |
Looking for a particular ThrombInnov employee's phone or email?
Pierre Mangin is the Chief Scientific Officer of ThrombInnov.
2 people are employed at ThrombInnov.